NKTT-120

DB17730InvestigationalProtein Based Therapies

NKTT-120 is a recombinant humanized IgG1k monoclonal antibody to human invariant T cell receptor (iTCR).

Mechanism: Pharmacologically active on High affinity immunoglobulin gamma Fc receptor I and Low affinity immunoglobulin gamma Fc region receptor III-A
Curator reviewed
Code names: NKT-14 · NKTT-120

Resolves to

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with NKTT-120, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.